关于 "Ligand for E3 Ligase" 的结果28+ 个结果

筛选:Signaling Pathways×
  • GC61200 structure
    Pomalidomide-PEG1-C2-N3
    CAS: 2271036-44-1

    Pomalidomide-PEG1-C2-N3是一种合成的E3连接酶配体-linker偶联物,包含基于Pomalidomide的cereblon配体和1个单元PEG的linker。Pomalidomide-PEG1-C2-N3可通过PROTAC技术合成选择性的CDK6降解剂CP-10。CP-10诱导CDK6降解,DC50为2.1nM。

  • GC60009 structure
    (S,R,S)-AHPC-PEG5-COOH
    CAS: 2172820-14-1

    (S,R,S)-AHPC-PEG5-COOH (VH032-PEG5-COOH) 是一种合成的 E3 连接酶配体-linker 偶联物,包含基于 (S,R,S)-AHPC 的 VHL 配体和 5 个单元 PEG linker。

  • GC59051 structure
    THPTA ligand
    CAS: 760952-88-3

    三(3-羟丙基三唑甲基)胺(THPTA) ligand是一种水溶性配体。

    Signaling Pathways
  • GC50718 structure
    VH 032 amide-alkylC3-acid
    CAS: 2172819-73-5

    Functionalized von-Hippel-Lindau protein ligand (VHL) for research and development; incorporates an E3 ligase ligand plus alkylC3 linker with terminal carboxylic acid ready for conjugation to a target protein ligand

  • GC73529 structure
    FAP Ligand 1
    CAS: 2230625-76-8

    FAP Ligand 1(FL)是一种高亲和力FAP小分子配体,用于将附着的药物靶向表达FAP的成纤维细胞,可用于靶向癌症的放射成像研究。

  • GC71382 structure
    RNF114 ligand 1
    CAS: 900137-36-2

    RNF114 ligand 1是E3泛素连接酶粘合剂。

  • GC71404 structure
    hRIO2 kinase ligand-1
    CAS: 923841-73-0

    hRIO2 kinase ligand-1(com 9)是hRIO2激酶的配体,Kd值为520 nM。

  • GP10085 structure
    Thrombin Receptor Activator for Peptide 5 (TRAP-5)
    CAS: 141685-53-2

    凝血酶受体激活剂 5 (TRAP-5) 也称为凝血因子 II 受体 (1-5) 或蛋白酶激活受体 1 (1-5),用于研究冠心病 (CHD)。

  • GC45063 structure
  • GC63543 structure
    Thalidomide-NH-CBP/p300 ligand 2
    CAS: 2484739-21-9

    Thalidomide-NH-CBP/p300 ligand 2 (P-007) 是 CBP 和 p300 的 PROTAC 降解剂。

  • GC12347 structure
    Sulforhodamine 101
    CAS: 60311-02-6

    A red fluorescent dye

  • GC50665 structure
    Pomalidomide 4'-alkylC3-acid
    CAS: 2225940-47-4

    Functionalized cereblon ligand for research and development; incorporates an E3 ligase ligand plus an alkylC3 linker with terminal acid ready for conjugation to a target protein ligand

  • GC52425 structure
  • GC50669 structure
    Lenalidomide 4'-PEG1-amine
    CAS: 2624336-86-1

    Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG1 linker with terminal amine ready for conjugation to a target protein ligand

  • GC50674 structure
    Pomalidomide 4'-alkylC4-acid
    CAS: 2225940-48-5

    Functionalized cereblon ligand for PROTAC(R) research and development; incorporates an E3 ligase ligand plus an alkylC4 linker with terminal acid ready for conjugation to a target protein ligand

  • GC50684 structure
    Lenalidomide 4'-PEG2-amine
    CAS: 2624336-88-3

    Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG2 linker with terminal amine ready for conjugation to a target protein ligand

  • GC50689 structure
    Pomalidomide 4'-alkylC6-acid
    CAS: 2225940-50-9

    Functionalized cereblon ligand for PROTAC(R) research and development; incorporates an E3 ligase ligand plus an alkylC6 linker with terminal acid ready for conjugation to a target protein ligand

  • GC50694 structure
    Lenalidomide 4'-PEG3-amine
    CAS: 2624336-87-2

    Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG3 linker with terminal amine ready for conjugation to a target protein ligand

  • GC50696 structure
    Pomalidomide 4'-alkylC8-acid
    CAS: 2305936-70-1

    Functionalized cereblon ligand for PROTAC(R) research and development; incorporates an E3 ligase ligand plus an alkylC8 linker with terminal acid ready for conjugation to a target protein ligand

  • GC50731 structure
    VH 032 amide-PEG4-amine
    CAS: 2446474-04-8

    Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG linker ready for conjugation to a target protein ligand

  • GC50709 structure
    Thalidomide 4'-oxyacetamide-alkylC1-PEG3-alkylC3-amine
    CAS: 2564466-93-7

    Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkylC1-PEG3-alkylC3 linker with terminal amine ready for conjugation to a target protein ligand

  • GC50712 structure
    VH 032 amide-alkylC2-acid
    CAS: 2172819-72-4

    Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus alkylC2 linker with terminal carboxylic acid ready for conjugation to a target protein ligand

  • GC50723 structure
    VH 101 phenol-alkylC4-amine
    CAS: 2564467-03-2

    Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkylC4 linker with terminal amine ready for conjugation to a target protein ligand

  • GC50724 structure
    VH 032 amide-alkylC6-acid
    CAS: 2172819-75-7

    Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus alkylC6 linker with terminal carboxylic acid ready for conjugation to a target protein ligand